The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Remember gents that we had £2m in the bank from the RMS sale. So either way it’s an educated purchase by the BoD, be it for manufacturing or further investment and not necessarily using any of the placing funds.
If you look at the share purchases on Volocity recently there’s more to it. More than 1.5mil share have been bought in recent times. For a firm that doesn’t seem to do much share dealings on a daily/weekly basis!? Is TB having a side dabble like with Chamberlain?? Questions questions!!
ZEPHI your not even elaborating in your text or title what you’re actually going on about. So why bother this BB with your blindness. Do some proper research and don’t cherry pick fragments of actual fact and add it to your aimless assumptions.
Jog on time waster!!
X30 - I would say from discussions with it saying engagement, and they’ve been engaged a fair few months now. Hence the placing happening to either force the hand of the manufacturer to give a good offer for the Covid test, or as mentioned by TB, he’ll take it to market independently using the placing monies.
Guys just a reminder of an older post I did. There is a webinar by VUMC on the 21 Sep for the AD
Julius Clinical and Amsterdam UMC are proud to present the webinar: Cutting-edge developments in blood-based biomarkers for Alzheimer’s; application in clinical trials.
During this live webinar, Charlotte Teunissen, Professor in Neurochemistry at Amsterdam UMC will touch upon: o Patient selection o Patient stratification o Outcome measures
Theme: Biomarkers in Alzheimer's disease
Target audience: Pharmaceutical and biotech companies
Main language: English
You don’t do this if the product is inconclusive!? DYOR :)
The above was curtesy of Castle, who took the time to follow up on Starknights research into Amsterdam UMC
Cheers for the weblink Castle. Found this in the future events regarding AD. Cutting edge developments it states. You don’t call it that unless it’s going places imao
Webinar: Cutting-edge developments in blood-based biomarkers for Alzheimer’s; application in clinical trials
Congress & symposium
Start date:
21 september 2021
Julius Clinical and Amsterdam UMC are proud to present the webinar: Cutting-edge developments in blood-based biomarkers for Alzheimer’s; application in clinical trials.
All waiting with baited breath for RNSs x several towards the end of September/early October. Lots of traders folding GDR as no profit for them in the short-term (day to week). Lots of small volume sales.
Hang on in there and look at the rest of your portfolio for a few weeks, or go stir crazy here.
FOMO will build about 20th onwards. To soon at present
Still a bit of a wait for news, so it’s likely to drift lower slowly. MMs picking off stop losses and ill informed investors selling is creating the share movement. Most buyers I guess are placed now and IIs waiting for a clear movement which the next couple of RNSs will give
Isn’t the efficiency against the algorithms being used? Hence patents being required to stop the anonymous crypto expert taking the intellectual property and using it for their own means/gains be that personal use or with other crypto mining businesses?